27 episodes

A podcast designed to put the spotlight on the most important issues in the pharmaceutical and healthcare space — hosted by Ekta Batra.
TheMedicineBox provides a sharper vision of the future of the pharma and healthcare industry to see where it is headed.

The Medicine Box CNBC-TV18

    • Business

A podcast designed to put the spotlight on the most important issues in the pharmaceutical and healthcare space — hosted by Ekta Batra.
TheMedicineBox provides a sharper vision of the future of the pharma and healthcare industry to see where it is headed.

    28: Research and development in healthcare

    28: Research and development in healthcare

    • 23 min
    27: Emerging business models in the pharmaceutical industry

    27: Emerging business models in the pharmaceutical industry

    • 25 min
    26: public & private partnerships in healthcare

    26: public & private partnerships in healthcare

    The podcast, hosted by CNBC-TV18’s Ekta Batra, and in association with OPPI, which represents research-based pharmaceutical companies in India, has six episodes. The third episode features N Rajaram, Boar Member OPPI and managing director of Sanofi India. He discusses public-private partnerships in healthcare and shares vital insights on how one can deliver better health outcomes. Tune in!

    • 20 min
    25: Healthcare financing models in India

    25: Healthcare financing models in India

    In the latest series of The Medicine Box, top executives of the Organisation of Pharmaceutical Producers of India (OPPI) and India-based MNCs speak on a range of topics related to the pharma and healthcare industry.

    The podcast, hosted by CNBC-TV18’s Ekta Batra, and in association with OPPI, which represents research-based pharmaceutical companies in India, will have six episodes.

    In the second episode of the series, Ekta chats with A Vaidheesh, OPPI president, and managing director, India of Glaxo SmithKline Pharmaceuticals Limited. Vaidheesh discusses India’s Missing Middle, in the context of Ayushman Bharat & healthcare financing in the country. Listen to him share his thoughts on the current healthcare financing models in India, the need for change and solutions such as increasing insurance coverage. Tune in!

    • 17 min
    24: Innovation in healthcare policymaking

    24: Innovation in healthcare policymaking

    The Indian pharmaceutical industry, which is expected to touch $130 billion by 2030, is the largest provider of generic medicines globally, producing 20 percent of world’s medicines. India, called ‘pharmacy to the world’, is the source of 60,000 generic brands across 60 therapeutic categories and home to 3,000 pharma companies with a network of more than 10,500 manufacturing facilities. Despite these promising statistics, the country’s healthcare sector is not in the pink of health. The challenges include skyrocketing out-of-pocket expenditure, pricing of patented drugs, spurious medications and regulatory loopholes.

    • 23 min
    22: Research Delta's Nimish Mehta talks about Para IV and potential opportunities

    22: Research Delta's Nimish Mehta talks about Para IV and potential opportunities

    The guest on today’s The Medicine Box podcast is Nimish Mehta, founder of pharma- and health-focused advisory Research Delta Advisors. Nimish’s experience in the pharma space spans more than two decades including consulting and advisory on M&A, exit, entry decisions. He joins in today to discuss what a Para IV is and he lists out any potential Para IV opportunities he foresees for specific pharma companies.

    • 21 min

Top Podcasts In Business

Listeners Also Subscribed To